IndexIntroduction and context of stem cellsAnalysis of the stem cell dilemmaProposed strategiesHealth policy that regulates and addresses the dilemmaConclusionReferencesStem cell research has enabled researchers and healthcare professionals to understand the human body and develop new treatments for diseases, the use of stem cells, especially embryonic ones, remains a controversial issue. Although medicine contains many known principles and theories, opportunities for experimentation remain, which are subject to ethical scrutiny. Science and research have enabled Americans to live healthier lifestyles, with many Americans living significantly longer than the previous generation. The purpose of this article is to examine the ethical dilemma surrounding stem cell research. Included in this discussion will be the introduction, context, analysis, proposed health system strategies, and health policy related to stem cell research and therapy. Say no to plagiarism. Get a tailor-made essay on "Why Violent Video Games Shouldn't Be Banned"? Get an Original Essay Stem Cell Introduction and Background Stem cell research is not new and began in the United States in the 1950s. Stem cells are the building blocks of normal growth and development. They are essential for rebuilding and repairing damaged tissues. Numerous degenerative diseases such as degenerative retinal disease or osteoarthritis result from the malfunction of a specific type of cell, which has the potential to be treated through stem cell therapy. Stem cells have the ability to grow and adapt for a specialized function that is determined by location in the tissue (differentiation). For example, liver cells placed in the liver will become part of the liver. Reisman and Adams explained that embryonic cells have not yet acquired a specific role and therefore are able to differentiate and divide to reproduce multiple copies of these cells with extreme efficiency. Analysis of the Stem Cell Dilemma While stem cell research is very promising, the use of embryonic stem cells is an ethical dilemma among researchers and the public. The ethical dilemma centers on the question of when life begins. Supporters hope for stem cell research as the answer to repairing organ and tissue damage caused by diseases such as Parkinson's disease, multiple sclerosis and type I diabetes. Opponents consider the use of embryonic stem cells in as a human embryo is a human individual in an early stage of development. While opponents do not deny the potential benefits of using embryonic stem cells, one wonders whether the ends justify the means. Embryonic stem cells are pluripotent cells that can transform into all types of cells that make up the human body. Pluripotent stem cells can be obtained from fetal tissue after abortion and, as a result, raise ethical and controversial dilemmas for individuals who oppose abortion. Likewise, the destruction of human embryos continues to be a major factor in slowing the progress of hESC development and use due to conflict with the religion and beliefs of many individuals. However, the first provision of the Code of Ethics for Nurses provides for the protection, promotion and restoration of patients' health. It is necessary to consider the right of the sick patient and ensure easy access to the advantages of stem cell therapy for the treatment of a diseaseterminal. The argument here is that more lives will be saved by using donated embryonic stem cells. Proposed Strategies The issues surrounding stem cell research involve developing processes that help ensure there are donor education programs, explicit informed consent, and protect the privacy and confidentiality of donors and donors. recipients. Consent forms are collected from the donor and recipient. These consent forms should contain all identified risks, benefits and alternatives to the procedure. Advance Practice Registered Nurses (APRNs) and Doctor of Nursing Practices (DNPs) have the responsibility to safeguard the integrity of individuals and adopt a process that respects the values ​​and desires for fairness of all involved in the stem cell research process . Provisions seven and eight of the Code of Conduct require the involvement of nurses in research and professional development to ensure quality health care and reduce health disparities. Two ethical principles to remember here are beneficial and non-malefic. This would include providing compassionate care with autonomy to make an informed decision and avoid harm to others based on our individual beliefs and values. The three essential elements of the DNP guide APRNs to participate in evidence-based practices (EBPs) that would ensure health promotion and disease prevention of all individuals in the community. We also know that EBP is about integrating the best research evidence and clinical expertise with consideration of patient needs to provide quality, safe and cost-effective healthcare, excellent customer service and optimal outcomes. However, translating research into practice settings and integrating EBP into nursing practice has been challenging. One major contributing factor is that studies have shown that nurses' cultural beliefs have prevented this implementation in numerous healthcare settings. In general, nurses have a positive attitude towards evidence-based practice; however, this behavior should be eliminated to allow EBP to become a daily practice that benefits all patients. Federal funding and restrictions should be monitored and controlled to safeguard social justice and equity. A group or committee can develop guidelines and monitor stem cell research and therapy so that they are conducted in a socially just manner and promote and ensure the essential elements of social justice. Individuals with a utilitarian approach seek to maintain social justice based on the effect an intervention would have on community members. They will select the intervention that would benefit the majority. A libertarian individual recognizes the right to life, liberty and property and respects the rights of others. They ensure that all services are available regardless of social and economic status and that denial of services is not based on race, ethnicity, or politics when treatment is needed to save lives. The third provision of the Code of Conduct requires the nurse to promote and advocate for the health and safety of all patients. Therefore, the goal should be to make stem cell research and therapy available to all. The cost of integrating stem cell research and therapies into clinical practice is high, however it is a resource that should be allocated and distributed so that everyone benefits. This will require the DNP to participate in monitoringcontinuous attention to policies and practices aimed at ensuring fair and ethical use. under the spotlight with huge expectations. Stem cell research and technology has exploded in recent years since embryonic cells were first isolated in 1998. The role of each agency is slightly different, but they all contribute by providing the infrastructure or influencing cell research stem. In the United States, research abuses drove National's 1974 boost, which created the National Commission for the Protection of Stem Cells. Human subjects of biomedical and behavioral research. In 1978, the Commission published Ethical Principles and Guidelines for the Protection of Human Research Subjects, also known as the Belmont Report. This identified three fundamental ethical principles for all human research to ensure respect for individuals, beneficence, non-maleficence and justice. ILThe term beneficence is defined as trying to help others and not maleficence as forcing individuals not to harm others. The infrastructure for stem cell projects is entrusted to the National Institute of Health (NIH). All acceptable stem cell-related research must be submitted, listed, and approved through the NIH. The subcomponents of the NIH are the Research Centers or Resources Organization (NCRRO), the Institute on Aging (NIA), the Institute of Child Health and Human Development (NICHD), and the Institute for diabetes and digestive and kidney diseases (NIDDK). Within these different subcomponents is the actual process of developing treatments for the major diseases and conditions that affect Americans every day. With the increasing use of human embryonic stem cells (hESCs) in understanding and treating degenerative diseases, there were people who resisted the idea of ​​destroying human embryos. In response, in 2001, President Bush signed a bill that allowed the federal National Institutes of Health (NIH) to fund stem cell research only for those embryonic stem cell lines produced before 2001. This was a major incentive to involve more researchers in research. increase the chances of therapeutic breakthroughs to cure diseases that would normally kill individuals. In cases involving blastocysts, gametes, and somatic cells for research purposes, the procurement process requires institutional review board (IRB) approval. The membership and functions of the IRB are described in the Department of Health and Human Services (DHHS) regulations at 45 CFR 46.107-115. The DHHS's mission is to protect human research subjects and extends its protection to vulnerable populations such as pregnant women, viable fetuses, prisoners and children. The Food and Drug Administration Center (FDA) regulates human cells, tissues, and cells and tissues. bio-based products for evaluation and research on organic products. This covers all purposes of implantation, transplantation, infusion or transfer into a human recipient, including stem cells. Please note: this is just a sample. Get a custom paper from our expert writers now. Get a Custom Essay Conclusion While stem cell research continues, for patients suffering from deadly diseases such as Parkinson's disease, multiple sclerosis, and type I diabetes, its progress is slow and controversial. The fundamental question of when life will begin remains at the heart of the stem cell research dilemma. As science advances, the moral dilemma remains to be reconciled between government and society. In the hope of a cure, patients seek treatment with therapies.21666